Moderna reiterates up to 10% 2026 revenue growth while lowering cash cost guidance to ~$4B

EarningsPositive

AI Analysis

Moderna reiterates its 2026 revenue growth guidance of up to 10% while lowering cash cost guidance to approximately $4 billion.

Revenue

up to 10% growth in 2026

Guidance

cash cost guidance lowered to ~$4B

Importance:5/10

Sentiment:

0.30

guidancerevenuecost reduction2026 outlook

Related Companies

Read the original article

Published by Seeking Alpha Healthcare on July 31, 2026 4:05 PM